Mutation in the MAP4K3 gene sequence was predicted to modulate cancer progression [35], and this hypothesis was supported by abnormal levels of MAP4K3 expression in pancreatic cancer tissues and enhanced cellular proliferation by RNAi-induced suppression of MAP4K3 [36]. This evidence concerns the gene MAP4K3 and familial pancreatic carcinoma.